The COVID-19-Associated Mucormycosis with Cutaneous Involvement
Related Experiment Video
Updated: Jun 9, 2025
Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
Published on: October 27, 2023
Neel Prabha1, Ripu Daman Arora2, Anju George C3
1Department of Dermatology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India; ripuneel@gmail.com.
Abstract:
Mucormycosis is an invasive fungal infection caused by fungi of the order Mucorales. During the coronavirus disease 2019 (COVID-19), a rise in the number of COVID-19-associated mucormycosis (CAM) patients was reported globally. Cutaneous mucormycosis is the third most common presentation of mucormycosis. It is classified as primary cutaneous and secondary cutaneous mucormycosis. The secondary form is more common than the primary cutaneous; however, most reports and case series in the literature are that of primary cutaneous mucormycosis. We accounted a case series of eight patients of CAM with secondary cutaneous mucormycosis.
Insights
This study presents a case series of secondary cutaneous mucormycosis in eight patients with COVID-19-associated mucormycosis (CAM). It highlights the underreported secondary form of this invasive fungal infection.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Dermatology
Background:
- Mucormycosis is a severe invasive fungal infection caused by Mucorales.
- A global increase in COVID-19-associated mucormycosis (CAM) has been observed.
- Cutaneous mucormycosis, a common form, is categorized into primary and secondary types.
Purpose of the Study:
- To report a case series of secondary cutaneous mucormycosis in CAM patients.
- To address the underrepresentation of secondary cutaneous mucormycosis in existing literature.
Main Methods:
- Retrospective case series analysis.
- Inclusion of eight patients diagnosed with CAM and secondary cutaneous mucormycosis.
Main Results:
- Eight cases of secondary cutaneous mucormycosis in CAM patients were identified.
- This series contributes to the understanding of the secondary form of cutaneous mucormycosis.
Conclusions:
- Secondary cutaneous mucormycosis is a significant, yet underreported, manifestation of CAM.
- Further research and clinical attention are warranted for secondary cutaneous mucormycosis in the context of COVID-19.
Related Concept Videos
01:23Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
01:29Fungal Group Zygomycota